Subsequent entry biologics: a new paradigm *

Canada - April 22 2013
There are several biologic drugs approved for use in Canada comprising an estimated 14-16 per cent of the prescription pharmaceutical market. Health…

Co-authors: Melissa A. Binns, Patrick Stewart Smith .

---

Northern exposure? *

Canada, USA - April 4 2013
Davit Akman and John Norman suggest that a recently commenced investigation into alleged "product switching" and statements by the Interim…

Co-authors: Davit Akman .

---

Abuse of patents in Canada *

Canada - August 3 2012
Patents encourage ingenuity by rewarding the disclosure of an invention to the public.

Co-authors: Constance Too, Xiang Lu.

---

Supreme Court of Canada limits Health Canada's ability to disclose commercially sensitive information *

Canada - February 6 2012
On February 3, 2012, the Supreme Court of Canada released a decision that limits Health Canada’s ability to disclose an innovator’s commercially sensitive pharmaceutical product information to competitors.

Co-authors: Wendy J. Wagner , Anastasia Semenova .

---

Europe wants Canada to update patent laws *

Canada, European Union - March 15 2011
Canada is currently negotiating a comprehensive economic trade agreement with the European Union to increase the volume of trade and business occurring between Canada and Europe.

Co-authors: Esmaeil Mehrabi.

---